Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$60.7M Buy
5,239,754
+4,589,937
+706% +$25.9M 0.03% 662
2026
Q1
$1.95M Buy
+649,817
New +$1.88M ﹤0.01% 2934
2025
Q3
Sell
-17,908
Closed -$46K 4514
2025
Q2
$46K Buy
+17,908
New +$50.4K ﹤0.01% 4176
2024
Q4
Sell
-245,770
Closed -$939K 4352
2024
Q3
$939K Sell
245,770
-87,924
-26% -$350K ﹤0.01% 3321
2024
Q2
$1.03M Sell
333,694
-63,339
-16% -$294K ﹤0.01% 3183
2024
Q1
$2.26M Buy
397,033
+221,293
+126% +$997K ﹤0.01% 2547
2023
Q4
$738K Buy
+175,740
New +$326K ﹤0.01% 3329
2022
Q3
Sell
-28,727
Closed -$95K 5140
2022
Q2
$95K Buy
+28,727
New +$143K ﹤0.01% 4740

Other funds holding ABSI

David Shaw's ABSI Position: Q2 2026 in Review

David Shaw increased its Absci (ABSI) stake by 706% in Q2 2026, buying an estimated $25.9M and bringing the position to 5,239,754 shares worth $60.7M. The position accounts for 0.03% of the portfolio, ranked #662.

David Shaw first reported a position in ABSI in Q2 2022 and has held it in 8 quarters since. 196 funds tracked by Wall St. Rank hold ABSI as of Q2 2026.

  • David Shaw held 5,239,754 shares of Absci worth $60.7M as of Q2 2026.
  • David Shaw bought 4,589,937 Absci shares in Q2 2026, an estimated $25.9M.
  • Absci made up 0.03% of David Shaw's portfolio in Q2 2026, its #662 holding.
  • David Shaw first reported a position in Absci in Q2 2022 and has held it in 8 quarters since.
  • 196 funds tracked by Wall St. Rank held Absci as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.